English
Specials
Upgrade

Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Get App Open
In App
Open App

LIVE COVERAGE AND VIDEO PARTNERS

Lenovo Tech Today India Prestige Group Acer India ENO

PARTNERS

Tata AIA Life Insurance
Hafele
Motilal Oswal
SMC Global Securities Limited
SBI Life
DSP Mutual Fund
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - JB Chemicals and Pharmaceuticals

JB Chemicals and Pharmaceuticals

BSE: 506943|NSE: JBCHEPHARM|ISIN: INE572A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 07, 16:01
2002.25
-12.25 (-0.61%)
VOLUME 1,653
LIVE
NSE
Feb 07, 15:46
2014.65
-5.55 (-0.27%)
VOLUME 20,896
News on JB Chemicals and Pharmaceuticals
Last: 30 DAYS 3 MONTHS 6 MONTHS
Select Year: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
JB Chemicals Consolidated September 2021 Net Sales at Rs 593.01 crore, up 33.69% Y-o-Y

2.22 pm | 12 Nov 2021 |  Source: Moneycontrol.com

NULL...

Exclusive: KKR-controlled drug maker JBCPL evaluating acquistion of select brands, mid-sized firm

1.12 pm | 24 Jun 2021

KKR's deep pockets and expertise is expected to help JBCPL to expand quickly using both organic and inorganic options. KKR bought a controlling st...

JB Chemicals Consolidated March 2021 Net Sales at Rs 528.46 crore, up 19.14% Y-o-Y

9.00 am | 17 Jun 2021 |  Source: Moneycontrol.com

NULL...

JBCPL launches new division offering therapies targeting kidney diseases

2.58 pm | 06 May 2021 |  Source: Moneycontrol.com

The new division will focus exclusively on comprehensive renal care ranging from the management of hypertension in Chronic Kidney Disease to End-stage...

Buy JB Chemicals and Pharmaceuticals; target of Rs 1356: Dolat Capital Market

2.09 pm | 04 Mar 2021 |  Source: Moneycontrol.com

Dolat Capital Market is bullish on JB Chemicals and Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1356 in its rese...

JB Chemicals Standalone December 2020 Net Sales at Rs 500.34 crore, up 29.97% Y-o-Y

12.00 pm | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

JB Chemicals Consolidated December 2020 Net Sales at Rs 548.22 crore, up 27.9% Y-o-Y

12.00 pm | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

1
Quick Links for JB Chemicals and Pharmaceuticals
Related Searches JB Chemicals and Pharmaceuticals Stock Price, JB Chemicals Stock Quote, JB Chemicals Results , JB Chemicals News .. More »
Follow moneycontrol

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI AndroidWindow

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Budget 2019 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Pune | Online Shopping in India  | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore | Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.